Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
FDA versnelt goedkeuring copanlisib bij recidiverend folliculair lymfoom
sep 2017 | Lymfoom